Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. - Wikidata - awgldk - TriplyDB

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

http://www.wikidata.org/entity/Q46871110

about

Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activity Topical microbicides for prevention of sexually transmitted infections Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses Preconception care: delivery strategies and packages for care Rectal pre-exposure prophylaxis (PrEP)Preconception care: preventing and treating infections Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa Microbicides and their potential as a catalyst for multipurpose sexual and reproductive health technologies Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study New candidate biomarkers in the female genital tract to evaluate microbicide toxicity A macaque model to study vaginal HSV-2/immunodeficiency virus co-infection and the impact of HSV-2 on microbicide efficacy An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaques New Biomedical Technologies and Strategies for Prevention of HIV and Other Sexually Transmitted Infections Adherence in the CAPRISA 004 tenofovir gel microbicide trial Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide Lignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmission Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice Polyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infection Safety, adherence and acceptability of intermittent tenofovir/emtricitabine as HIV pre-exposure prophylaxis (PrEP) among HIV-uninfected Ugandan volunteers living in HIV-serodiscordant relationships: a randomized, clinical trial Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy Development of a composite measure of product adherence, protocol compliance, and semen exposure using DNA and protein biomarkers for topical HIV prevention studies Expression of Genes for Drug Transporters in the Human Female Genital Tract and Modulatory Effect of Antiretroviral Drugs The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development Iota-carrageenan is a potent inhibitor of influenza A virus infection Structure activity relationship of dendrimer microbicides with dual action antiviral activity Women and HIV in Sub-Saharan Africa.HIV-prevention science at a crossroads: advances in reducing sexual risk.HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities.Nanotechnology and HIV: potential applications for treatment and prevention.Combinatorial approaches to the prevention and treatment of HIV-1 infection Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.Overview of microbicides for the prevention of human immunodeficiency virus.The importance of the vaginal delivery route for antiretrovirals in HIV prevention.Controlling the HIV/AIDS epidemic: current status and global challenges Efficacy dilution in randomized placebo-controlled vaginal microbicide trials Adherence and its measurement in phase 2/3 microbicide trials.Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.

P2860

Q21144588-86815319-E825-4D3D-89FC-60140F1AB319 Q21203732-97DBBB80-2C5A-4E1B-A0CC-CFF945D89262 Q21562543-120CFBBA-6F00-4C2E-B1ED-83CEE1119CA9 Q24202832-5B8042B7-775B-4DE8-BB42-DC145963D760 Q26774878-960DABD1-370D-4739-A464-D951037F6CC1 Q26828937-74DA2BCB-B0D3-4376-8A2A-234D357405D4 Q26829713-18E2B0C0-0A61-45AD-86B9-C92B3A992E03 Q26996391-491628F6-68BB-4356-9D5C-8E0D3B4F528A Q27022927-53C9BA15-5191-4FA1-8249-6AB95A12067B Q27026257-8BF9E9F5-073F-4E1B-BD62-FA3C1E8EE51B Q27300707-F9D98D7B-6638-4E03-8B7B-C2329796A35F Q27334382-4FFB9EAC-9ACF-4BEB-8257-7B5832773A22 Q27335068-D97C8A0D-5720-4A03-B615-EAA1ECD6463E Q27438093-5E0A849B-643B-49CF-AEEB-BA4FB99C8AFA Q28072213-E0D5F010-0098-4F59-9386-9BEF8353E8E2 Q28236148-C46AE4FF-77EA-4BF3-8966-F002C84CF2DF Q28260539-0F466592-8FB6-4F3F-A9EF-E44D2CB7BD8F Q28472968-B5C8FF48-0B79-47F4-A9C0-ADA661D2FD2C Q28482818-8E7FD527-C804-4BED-913E-037983EAA88E Q28488527-5C898FD2-584C-498E-841F-BABEE12FE8FA Q28489042-9E67466E-2863-4A10-9DCD-EDB832509134 Q28533828-D75A2BE8-F649-4BC2-BCDF-A983540000E1 Q28540419-3E370EEB-42D5-499D-8370-68082A6D5084 Q28542608-944B30D5-B34A-4403-A2D0-1C6DA9ABB518 Q28548592-6045B8B6-4EE2-4EBC-8F53-52475F2CAFB4 Q28551783-EBD853F3-6710-48E0-A3D6-99418F926888 Q28744254-9F62240B-1872-441D-9C2B-0F967EECF104 Q28749596-F29A3B8A-7BD4-45E9-9850-FDE166B1E1C2 Q30356708-5D2F4918-C204-404C-A981-DC269B77A5A6 Q30378142-DC0B021D-C3BF-43B1-A46E-CC804A559BB1 Q30383181-CFDC059F-4DAE-4849-B4AC-06EDE00B8A44 Q30393980-5BC0F702-4E0E-4FA0-8478-EBD0D33C4F71 Q30400060-2ED48211-8228-466D-819F-568EC2F59AF0 Q30412592-D77537B1-28D8-4B9E-8CA9-1EB0A81D3699 Q30413777-9B4C7F5A-E202-4651-B419-2173CF54EE0A Q30414890-3313707D-E2D4-41D2-8988-D278BEB1DB3C Q30420558-E3D1572F-9056-476F-9E2D-C64DF950B087 Q30491264-87E11215-D42E-4690-B11A-228756F65DF0 Q30496720-31F37224-9CF4-4248-B81B-312267F4B864 Q30499386-326E3442-69DA-4751-9194-F5BA35CC23C0

P2860

Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.

http://www.wikidata.org/entity/Q46871110

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Efficacy of Carraguard for pre ...... ind, placebo-controlled trial.

@en

Efficacy of Carraguard for pre ...... ind, placebo-controlled trial.

@nl

type

label

Efficacy of Carraguard for pre ...... ind, placebo-controlled trial.

@en

Efficacy of Carraguard for pre ...... ind, placebo-controlled trial.

@nl

prefLabel

Efficacy of Carraguard for pre ...... ind, placebo-controlled trial.

@en

Efficacy of Carraguard for pre ...... ind, placebo-controlled trial.

@nl

P1433

Q46871110-406A7938-C6D0-4485-82F1-01FFD4DB8803

P1476

Q46871110-8AD7CE33-DAA5-47EF-B01A-76012648361A

P2093

Q46871110-14CC1F96-8C50-42B6-AFED-59BB78BAD75A

Q46871110-17019FD4-957C-4EC2-A985-9077F1F4A7FE

Q46871110-1E3995D7-3410-4E06-B51E-5329A0A040C4

Q46871110-2870B828-A7EC-402E-9C60-C9BADA153D7F

Q46871110-67AA7E85-B5DB-4699-8D9C-37DA929789B7

Q46871110-6E7A4420-B3EF-4AB9-BF40-437C66932C89

Q46871110-8262D2EA-8618-4253-AE09-EB83EFEC7B21

Q46871110-95087075-F802-4167-A4A2-DBD74351DC54

Q46871110-D1DB0A80-54CE-4FC4-B7E0-B081C898D882

Q46871110-D7635C11-3889-48BB-AD5A-95FB2039352C

P304

Q46871110-FCA0F199-B917-4B7E-8C84-0EE06829739E

P31

Q46871110-1EC3A38D-0873-4FC3-A6BF-2CF0369413E6

P356

Q46871110-5FC959FF-661D-4066-9309-F64532803810

P407

Q46871110-677836F5-05A3-42F0-A23E-AF333E3F6282

P433

Q46871110-C9FFBBEA-B6A3-442A-925F-F843A9A88E74

P478

Q46871110-4E07D652-E638-43EB-89EA-71A0C08D0DD4

P50

Q46871110-8521945F-8B40-4888-8C53-5BA4AC860E5E

P577

Q46871110-774575CE-3433-495A-805F-F1716870FE3C

P698

Q46871110-E21037C6-7730-4456-B136-1D20A7334E74

P921

Q46871110-7FFB616F-8988-4D70-A20D-8C80D2412B21

Q46871110-9D0FB3BE-65BF-4080-9719-F5B72051E126

Q46871110-AAFF1FBF-88E7-488E-B0EE-20383A6A0B64

P356

S0140-6736(08)61842-5

P1433

P1476

Efficacy of Carraguard for pre ...... ind, placebo-controlled trial.

@en

P2093

Alana De Kock

http://www.w3.org/2001/XMLSchema#string

Barbara Friedland

http://www.w3.org/2001/XMLSchema#string

Gregory Dozier

http://www.w3.org/2001/XMLSchema#string

Khatija Ahmed

http://www.w3.org/2001/XMLSchema#string

Lydia Altini

http://www.w3.org/2001/XMLSchema#string

Marlena Gehret Plagianos

http://www.w3.org/2001/XMLSchema#string

Nazira Cassim

http://www.w3.org/2001/XMLSchema#string

Pekka Lahteenmaki

http://www.w3.org/2001/XMLSchema#string

Robin Maguire

http://www.w3.org/2001/XMLSchema#string

Stephanie Skoler-Karpoff

http://www.w3.org/2001/XMLSchema#string

P304

1977-1987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(08)61842-5

http://www.w3.org/2001/XMLSchema#string

P407

P433

9654

http://www.w3.org/2001/XMLSchema#string

P478

372

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19059048

http://www.w3.org/2001/XMLSchema#string

P921

Aafrikaa Kibbaa

prevention of HIV/AIDS